These data suggest that Brca1 deficiency directs an immunosuppressive microenvironment characterized by markedly increased functional MDSCs with inhibition effect, which suppress effector T cell proliferation during tumor initiation and progression. This evidence concerns the gene BRCA1 and neoplasm.